Scientists from the American clinic Duke Health have discovered a set of biomarkers that can significantly improve the accuracy of diagnosing pancreatic cancer.. Thus, it will be possible to detect the disease at the earliest stages.. Writes about it Drug Target Review. The author of the study was Dr. Peter Allen. He and his team used digital spatial profiling of RNA, and thus were able to pinpoint genetic mutations in areas of the cyst with high and low levels of abnormal cell growth.. The team is currently working on identifying markers in the cyst fluid.. This could be the basis for a protein biopsy that can remove cysts before cancer develops and spreads.. " Pancreatic cancer is becoming more common and if the current trend continues it could soon become the second leading cause of cancer death in the US. The reason for the increase in the incidence is not yet known, but some research suggests that inflammation may be one of the contributing factors," We will remind, earlier, Chinese scientists have grown “mini-horns” in mice by embedding deer genes in them.. The body of an American began to produce alcohol. Subscribe to our channel https://t. me/korrespondentnet Author: 1.